Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

PET/CT metrics for differentiation of benign and malignant bone lesions in CRPC patients using [F-18]NaF PET/CT imaging

Timothy Perk, Hyung-Jun Im, Steve Cho, Scott Perlman, Glenn Liu and Robert Jeraj
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1428;
Timothy Perk
5Medical Physics University of Wisconsin- Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyung-Jun Im
6WCU, Seoul National University Seoul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Cho
3Radiology University of Wisconsin - Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Perlman
4University of Wisconsin Hospital and Clinics Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glenn Liu
1Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Jeraj
2University of Wisconsin Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1428

Objectives For accurate analysis of treatment response in patients with numerous bone lesions, benign lesions should be excluded from the analysis. This study aims to assess different metrics that can be extracted from consecutive [F-18]NaF PET/CT images and determine which metrics are useful for differentiation of benign and malignant bone lesions.

Methods 13 patients with advanced metastatic prostate cancer received pre-treatment and follow-up [F-18]NaF PET/CT scans under the course of chemotherapy or AR directed therapy. Three nuclear medicine physicians identified all lesions in the patients on the baseline images and by consensus determined which lesions were definitely benign and definitely malignant. A variable SUV threshold, based on background NaF uptake in different parts of the skeleton (skull, spine, pelvis, etc), was used for lesion segmentation on both baseline and follow-up images to allow for volumetric feature extraction. Articulated registration based matching was used to propagate lesion contours from baseline to follow-up scans. For each segmented lesion contour 3 standardized uptake value (SUV) metrics, 3 Hounsfield unit (HU) metrics, and lesion volume were extracted. The extracted metrics were maximum (max), mean, and standard deviation (hetero). Percent response of each metric to follow-up was also assessed. The distributions of these metrics for definite benign and definite malignant lesions were compared using t-tests. Using physician consensus as a gold standard, logistic regression analysis was performed using only baseline metrics and using response as well as baseline metrics were compared.

Results 350 malignant lesions and 45 benign lesions were identified by nuclear medicine physician consensus. Of these lesions, 25 malignant and 7 benign lesions were not detected at the follow-up scan. Linear regression models using baseline SUV metrics (AUCs of 0.76, 0.76, 0.74 for SUVmax, SUV¬mean, and SUVtotal, respectively) were better models than HU metrics (AUCs of 0.59, 0.61, 0.61 for HUmax, HU¬mean, and HUtotal, respectively). Volume was the worst baseline model (AUC=0.53). Adding the response values of a metric in every case improved the model by a small to moderate amount (AUC increases by between 0.01 to 0.7, p values from 0.007 to 1). Using all response metrics in addition to baseline metrics in a single model was found to only be slightly superior to a model using all the baseline metrics (AUC=0.82 vs AUC=0.79, respectively). However, ANOVA testing showed that the differences were not significant (p>0.05).

Conclusions Addition of response in addition to baseline values of metrics helps improve classification results coming from linear regression models. Additional metrics incorporated into more advanced classification algorithms could further improve the classification results.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PET/CT metrics for differentiation of benign and malignant bone lesions in CRPC patients using [F-18]NaF PET/CT imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PET/CT metrics for differentiation of benign and malignant bone lesions in CRPC patients using [F-18]NaF PET/CT imaging
Timothy Perk, Hyung-Jun Im, Steve Cho, Scott Perlman, Glenn Liu, Robert Jeraj
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1428;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PET/CT metrics for differentiation of benign and malignant bone lesions in CRPC patients using [F-18]NaF PET/CT imaging
Timothy Perk, Hyung-Jun Im, Steve Cho, Scott Perlman, Glenn Liu, Robert Jeraj
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1428;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Technical Advances and Quantification Posters

  • Quantitative Na-18F PET/CT Methodologies for Assessing Osteoblastic Tumor Burden
  • Characterization of yttrium-90 PET/CT as a tool to evaluate initial dosimetry and efficacy of yttrium-90 radioembolization.
  • Validation of Multi-level Otsu Method to Define Metabolic Tumor Volume in Positron Emission Tomography
Show more MTA I: Technical Advances and Quantification Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire